School of Medicine

Linda Repa-Eschen, former business director for the Division of Endocrinology, Metabolism & Lipid Research within the Department of Medicine at the School of Medicine, died June 5 at her home after waiting for a lung transplant. She was 72.

People with Down syndrome are at very high risk of developing Alzheimer’s disease. A project led by Jason Hassenstab, at the School of Medicine, aims to develop tools to measure cognitive function in people with Down syndrome-associated Alzheimer’s disease.

Members of minoritized racial or ethnic groups and people who live in less affluent neighborhoods are less likely than others to receive specialized care for dementia, including Alzheimer’s disease, a new study from the School of Medicine indicates.

Philip R.O. Payne, at the School of Medicine, has joined the steering committee of a National Academy of Medicine working group to draft a code of conduct for artificial intelligence in health, medical care and health research.

Scientists at Washington University have developed a breath test that quickly identifies those who are infected with the virus that causes COVID-19. The device requires only one or two breaths and provides results in less than a minute.

Beginning Wednesday, Aug. 2, applications will be open for the School of Medicine’s Executive Management Fellowship, a two-year program designed to provide participants with exposure to the operation and governance of a nationally ranked, research-based medical school and academic medical center.

Derek E. Byers, MD, PhD, has been named executive chair of the university’s Institutional Review Board, which reviews and approves protocols for research studies that involve human subjects. He begins the new role Tuesday, Aug. 1.

With support from a $3 million grant from the National Institutes of Health (NIH), a multidisciplinary team led by Hong Chen at the McKelvey School of Engineering seeks to integrate ultrasound with genetics to precisely modify neurons in the brain.

The Division of Physician-Scientists at the School of Medicine has named its 2023 Dean’s Scholars. The awardees will receive up to two years of financial support and mentorship, as well as dedicated lab time to conduct scientific research.

David T. Curiel, MD, PhD, and Michael S. Diamond, MD, PhD, both of the School of Medicine, have received the Chancellor’s Award for Innovation and Entrepreneurship for their development of a nasal vaccine against the virus that causes COVID-19.